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Mushrooms are important natural materials used in complementary medicine. In this context, the present study 
investigates the biological activities and phenolic content of mushroom Leucopaxillus gentianeus (Quél.) Kotl. Methanol 
(MeOH) and dichloromethane (DCM) extracts of the mushroom was used in the study. Total antioxidant status (TAS), total 
oxidant status (TOS) and oxidative stress index (OSI) were measured with Rel assay kits. DNA protective activity was 
determined with pBR 322 supercoil DNA. The effects of the extracts on lung cancer A549 cell line were tested to determine 
the cytotoxic effects. Antimicrobial activities were tested using 9 microorganisms with the modified agar dilution method. 
The mushroom MeOH and DCM extracts exhibited the highest activity against Candida glabrata, C. albicans and C. krusei. 
It was also determined that L. gentianeus had a high antioxidant potential. Furthermore, it was identified that DNA 
protective and cytotoxic activities of the mushroom were also present. Analysis for phenolic contents using HPLC revealed 
the presence of gallic acid, catechin, epicatechin, cinnamic acid, chlorogenic acid and coumaric acid. Overall results suggest 
that the mushroom L. gentianeus has considerable pharmacological potential, particularly anticancer, antimicrobial, 
antioxidant and DNA protective action. 
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Use of natural products in addition to synthetic drugs 
for the treatment of various diseases is not 
uncommon. However, side effects is an issue of 
concern with the synthetic drugs
1
. In this context, 
mushrooms are one of the important natural materials 
of the ecosystem
1,2
. Several mushroom species are 
used as natural nutrient and medicinal sources by 
people
3-5
. Mushrooms, like plants, contain compounds 
that possess different biological effects. Previous 
studies reported that these bioactive compounds have 
antioxidant, DNA protective, analgesic, antibacterial, 
antifungal, antiviral, antitumor, cytostatic, 
immunosuppressive, antiallergic, antiatherogenic, 
hypoglycemic, anti-inflammatory and hepato-
protective activities
5-8
. Thus, determination of the 
biological activities of mushrooms is important to 
identify new natural resources. 
 
Leucopaxillus gentianeus (Quél.) Kotl., commonly 
called Bitter false funnelcap or bitter brown 
leucopaxillus, grows under conifers and can be 
identified by its brown pileus, white lamellae and 
white stipe
9
. This study explored the phenolic 
compounds contents of L. gentianeus extract for its 
potential use as antioxidants, antimicrobials, DNA 
protective and anticancer resource. 
 
Materials and Methods  
 
The sample was collected during routine field 
surveys conducted in Gaziantep province in Turkey 
on 2017-2018. Morphological (shape, colour, size) 
and ecological properties of the samples were 
recorded in the field and the microscopic 
characteristics were recorded in the laboratory under 
suitable conditions with light microscopy using 3% 
KOH solution (Leica DM750). The samples were 





 The mushroom 
samples were dried at 40°C after the identification 
procedure. Dried mushroom samples were powdered 
with a mechanical grinder. Powdered mushroom 
samples were extracted with methanol (MeOH) and 
dichloromethane (DCM) in a Soxhlet device. 
 
TAS, TOS and OSI tests 
Total antioxidant status (TAS), total oxidant status 
(TOS) and oxidative stress index (OSI) of mushroom 
extract were determined with Rel Assay brand 








Trolox was used as TAS calibrator and the results 
were expressed as mmol Trolox equiv./L
12
. Hydrogen 
peroxide was used as TOS calibrator and the results 
were expressed as μmol H2O2 equiv./L
13
. The OSI 
(AU: Arbitrary Unit) expressed as the ratio of TOS 
levels to TAS levels, while the mmol value in the 
TAS unit was converted to μmol units similar to the 
TOS unit
13
. Analyses were conducted in 5 replicates. 
 
Antimicrobial activity test 
Antimicrobial activity tests of methanol (MeOH) 
and dichloromethane (DCM) extracts of mushroom 
were conducted with the agar dilution method 
recommended by the Clinical and Laboratory 
Standards Institute (CLSI) and the European 
Committee on Antimicrobial Susceptibility Testing 
(EUCAST)
14-16
. Minimal inhibitor concentrations 
(MIC) for each extract were determined against 
standard bacterial and fungal strains. Staphylococcus 
aureus ATCC 29213, S. aureus MRSA ATCC 43300, 
and Enterococcus faecalis ATCC 29212 were used as 
Gram-positive bacteria. Escherichia coli ATCC 
25922, Pseudomonas aeruginosa ATCC 27853 and 
Acinetobacter baumannii ATCC 19606 were used as 
Gram-negative bacteria. Candida albicans ATCC 
10231, C. krusei ATCC 34135 ATCC 13803 and  
C. glabrata ATCC 90030 were used as fungi. 
Bacterial strains were pre-cultured in Muller Hinton 
Broth medium, while fungal strains were pre-cultured 
in RPMI 1640 Broth medium. To obtain standard 
inoculum, the turbidity of bacteria and fungi was 
adjusted based on McFarland 0.5 scale. All extracts 
were tested at 800-12.5 μg/mL concentrations and 
distilled water was used to dilute all extracts. Solvents 
used for the extracts were also tested for antimicrobial 
activity. Fluconazole and amphotericin B were used 
as reference drugs for fungi, whereas amikacin, 
ampicillin and ciprofloxacin were used as reference 
drugs for the bacteria. The minimum dilution inhibitor 
concentration that inhibits the growth of bacteria and 





DNA protective activity test 
MeOH and DCM extract of mushroom DNA 
protective activities were determined using pBR 322 
supercoil DNA. Standard solutions (25, 50, 100 and 
200 μg/mL) were prepared using mushroom extracts. 
About 0.5 μg plasmid pBR 322 was added to 
supercoil DNA Eppendorfs and 10 μL of standard 
mushroom extract solutions were added. Further, 10 μL 
Fenton's agent (30 mM H2O2, 50 μM ascorbic acid 
and 80 μM FeCl3) was added to the prepared solution 
and the product was incubated at room temperature 
(20°C) for 10 min. The final volume of the mixture 
was adjusted to 20 mL and hkept for 30 min at 37°C. 
The DNA was then analyzed with electrophoresis on 




Antiproliferative effect test 
The MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl-tetrazolium bromide) was conducted on 
mushroom MeOH and DCM extract A549 cells to 
determine cell viability. Cells were separated in 3.0 mL 
Trypsin-EDTA solution (Sigma-Aldrich, MO, USA) 
after 70-80% confluence. Then, they were seeded on 
plates. The products were incubated for 24 h after 
seeding. Following the incubation, the extracts were 
diluted in different concentrations (5, 25, 50, 100 and 
200 μg/mL) and the cells were incubated for 24 h. 
Controls were conducted with growth medium 
without FCS supplement. After 48 h of incubation, 
the supernatants were dissolved in growth medium 
and exchanged with 1.0 mg/mL MTT (Sigma) and the 
purple precipitate was incubated at 37°C until 
formation of purple sediment. The supernatants were 
then removed, dissolved with dimethylsulphoxide 
(DMSO) (Sigma-Aldrich, MO, USA) added to the 
MTT absorbed by the cells. Plates were then read at 





Phenolics screening by HPLC 
The mushroom extract phenolic content was 
determined using an HPLC instrument. DAD detector 
was used as a detector. Injection volume was set as  
20 μL. As mobile phase, A: 3% acetic acid and B: 
methanol were used. The flow rate was adjusted to  
0.8 mL per minute. Chromatographic separation was 
performed at 30°C with an Agilent Eclipse XDB-C18 





All experiments were performed five times, and 
results expressed as mean ± standard deviation unless 
otherwise stated. Results were considered significant 
when P <0.05. 
 
Results and Discussion 
 
Antimicrobial activity tests 
Table 1 shows the antimicrobial activity of the 
methanol (MeOH) and dichloromethane (DCM) 
extracts of the Bitter false funnelcap Leucopaxillus 
gentianeus along with some common antibiotics 




(amikacin, ampicillin and ciprofloxacin) and antifungal 
medications (amphotericin B and fluconazole) for 
comparison. 
 
The MeOH extract exhibited higher activity on 
tested microorganisms. Antimicrobial activity of  
L. gentianeus has not been studied previously. 
However, different concentrations of L. giganteus, 
another Leucopaxillus species, has been reported to be 
effective against Escherichia coli, Klebsiella 
pneumoniae, Proteus mirabilis, Morganella 
morganni, Pseudomonas aeruginosa, Acinetobacter 
baumannii and Pasteurella multocida
23
. In a different 
study, it was reported that different concentrations of 
L. albissimus (Peck) Singer was effective against  
P. aeruginosa, Burkholderia cepacia, B. cenocepacia, 
B. multivorans, Stenotrophomonas maltophilia, 
Achromobacter xylosoxidans and Acinetobacter 
baumannii
24
. In the present study,the antimicrobial 
activity of the MeOH and DCM extracts L. gentianeus 
demonstrated that both extracts exhibited highest 
activities against C. glabrata, C. albicans and  
C. krusei at 50 μg/mL extract concentration. Extracts 
were also found to be effective against S. aureus,  
S. aureus MRSA, E. faecalis, E. coli, P. aeruginosa 
and A. baumannii at 100-400 μg/mL concentration.  
In conclusion, the antimicrobial activities of  
L. gentianeus were studied for the first time in the 
present study and it was found that 50 to 400 μg/mL 
concentrations were active against the test 
microorganisms. 
 
TAS, TOS and OSI  
Total antioxidant status (TAS), total oxidant status 
(TOS) and oxidative stress index (OSI) values of 
mushroom L. gentianeus were determined with Rel 
Assay kits. The TAS was 3.683±0.086 mmol/L, 
TOS, 6.303±0.181 μmol/L, and the OSI was 
0.171±0.006. Possibly, it is the first report on the 
TAS, TOS and OSI of L. gentianeus. In our previous 
oxidative stress studies on mushrooms, we have 
reported the TAS, TOS and OSI values of 1.748, 
19.294 and 1.106 μmol/L, for Lentinus tigrinus 
(Bull.) Fr.
25
; 2.332, 26.945, and 1.156 μmol/L for 
Terfezia boudieri Chatin
26
; and 1.44L, 14.21  
and 0.99 μmol/L for Fomitopsis pinicola (Sw.)  
P. Karst.
27
, respectively In other studies, the TAS 
value of Pleurotus eryngii (DC.) Quél and 
Cerioporus varius (Pers.) Zmitr. & Kovalenko have 




, respectively It is 
observed that L. gentianeus, used in the present 
study, had a higher TAS value compared to the 
above-reports. The TOS value of L. gentianeus is 
lower compared to that of L. tigrinus, T. boudieri 
and F. pinicola. This difference is due to the fact that 
L. gentianeus produces less reactive oxygen species 
in its native form. Furthermore, the low OSI value of 
L. gentianeus suggests that the mushroom tolerates 
the environmental and metabolic factors and oxidant 
compounds produced in the environment well 
through its endogenous antioxidant compounds. 
Overall, the mushroom L. gentianeus has been 
shown to have high antioxidant potential and it can 
be consumed as a natural antioxidant source. 
 
DNA protective activity 
The DNA protective activities of MeOH and 
DCM extracts of mushroom were determined using 
pBR 322 supercoil DNA. The findings are presented 
in Fig. 1, Oxidative damage on the DNA occurs due 
to production of ROS
30
. Free radicals can initiate or 
aggravate several diseases. Hydroxyl free radicals 
are known to be damage cellular DNA in humans, 
and they cause cellular cancer through partial 
damage to the DNA
31
. Fig. 1 demonstrates that 25, 
50, 100 and 200 μg/mL L. gentianeus MeOH and 
 
Table 1 — Antimicrobial Activity of Leucopaxillus gentianeus extracts 
  A B C D E F G H I 
MeOH 100 100 200 200 200 100 50 50 50 
DCM 100 100 400 200 400 200 50 50 50 
Ampicillin 1.56 3.12 1.56 3.12 3.12 - - - - 
Amikacin - - - 1.56 3.12 3.12 - - - 
Ciprofloxacin 1.56 3.12 1.56 1.56 3.12 3.12 - - - 
Fluconazole - - - - - - 3.12 3.12 - 
Amphotericin B - - - - - - 3.12 3.12 3.12 
[MIC values are presented in units of µg/mL. A, Staphylococcus 
aureus; B, S. aureus MRSA; C, Enterococcus faecalis; D, Escherichia 
coli; E, Pseudomonas aeruginosa; F, Acinetobacter baumannii; 
G, Candida albicans; H, C. glabrata; and I, C. Krusei. MeOH, 





Fig. 1 — DNA Protective activity of Leucopaxillus gentianeus 
extracts [M, Marker; P, DNA; P+R, Negative control: 
pBR322+OH radical; and 1, L. gentianeus; M, Methanol; and  
D, Dichloromethane] 
 




DCM extract concentrations exhibit significant 
protective activity against the hydroxyl radical. In 
the present study, rosmarinic acid was used as a 
positive control and exhibited strong DNA 
protection activity. MeOH extract @200 μg/mL 
resulted iin partial broke down Dof NA. Though the 
DNA protective activity of mushrooms in general 
are known, there are no reports available specific on 
L. gentianeus. Lee et al.
32
 reported natural 
antioxidant and potential DNA protective activities 
of mushrooms viz. Gloeophyllum trabeum (Pers.) 
Murrill, Daedalea dickinsii Yasuda, Pseudomerulius 
curtisii (Berk.) Redhead & Ginns, Stereum 
sanguinolentum (Alb. & Schwein.) Fr., Cryptoporus 
volvatus (Peck) Shear and Gloeophyllum abietinum 
(Bull.) P. Karst.
32
. Trametes gibbosa (Pers.) Fr., 
Fomes fomentarius (L.) Fr., Fuscoporia torulosa 
(Pers.) T. Wagner & M. Fisch., Daedalea quercina 
(L.) Pers., Inonotus hispidus (Bull.) P. Karst. and 
Trichaptum biforme (Fr.) Ryvarden have also been 
reported to be potential DNA protectors
21
, apart from 
Laetiporus sulphureus (Bull.) Murrill
33
. In our 
present study, we observed that L. gentianeus also 
exhibits potential DNA protective effect and  




MeOH and DCM extract of L. gentianeus 
standard solutions @25, 50, 100 and 200 μg/mL 
were prepared, and cell viability was tested with 
A549 lung cancer cell line. The findings are 
presented in Fig. 2. More than 60% of the deaths due 
to cancer and about half of the new cancer cases are 
witnessed in developing countries. Lung cancer is 
the most common type of cancer globally, followed 
by stomach, liver, colon, rectum and breast 
cancers
34
. It is the leading cause of cancer related 
deaths due to its high incidence, rapid progression 
and poor prognosis. Today, chemotherapy is widely 
used in the treatment of lung cancers. However, 
certain antitumor chemical drugs have serious 
adverse effects
35
. In this context, few mushrooms 
have been shown to possess anticancer potential. 
Previous studies have demonstrated that cucurbitacin 
B, cucurbitacin B esters, leucopaxillone A and 
leucopaxillone B isolated from L. gentianeus inhibit 
human lung carcinoma (A549), kidney carcinoma 
(CAKI 1), hepatoblastoma (HepG2), and breast 
adenocarcinoma (MCF-7) cell lines in different 
concentrations
36
. In the present study, L. gentianeus 
MeOH and DCM extracts demonostrated cytotoxic 
action on A549 cells. Fig. 2 shows strong 
antiproliferative effects of both MeOH and DCM 




Phenolic acids are known for their antioxidant 
activity
37
. Gallic acid is reported to have antioxidant, 
antimicrobial, antitumor and anti-inflammatory 
properties
38,39
. Catechin and epicatechin are known to 
exhibit antioxidant, antimutagenic, antimicrobial and 
anticancer action
40,41
. Cinnamic acid possesses anti-
inflammatory, antioxidative, antitumor, antimicrobial, 
antihypertensive and antihyperlipidemic activities
42
. 
Similary, chlorogenic acid exhibits antioxidant, 
antibacterial, anticancer, anti-inflammatory and DNA 
protective effects
43,44
. Coumaric acid has been shown 
to possess antioxidant, antimicrobial, immuno-
modulatory, anti-inflammatory, antiangiogenic, anti-
cancer, goitrogenic, antidiabetic and antihyper-
lipidemic activities
45,46
. In the present study, we have 
shown that all the above mentioned phenolic 
compounds are present in L. gentianeus (Table 2) 
indicating its huge potential. These six compounds 
gallic acid, catechin, epicatechin, cinnamic acid, 
chlorogenic acid and coumaric acid present in  
L. gentianeuscouold be responsible for its antioxidant, 
antimicrobial, DNA protective and cytotoxic effects 





Fig. 2 — Antiproliferative effects of Leucopaxillus gentianeus 
extracts (conc. 25, 50, 100 and 200 µg/mL). (A) MeOH; and  
(B) DCM 
 
Table 2 — Phenolic content of Leucopaxillus gentianeus (ppm) 
Gallic acid 27.55 
Catechin 130.77 
Epicatechin 21.31 
Chlorogenic acid 90.03 
Coumaric acid 1.28 
Cinnamic acid 34.37 
 





Results of this study, demonstrated high 
antioxidant potential of methanol (MeOH) and 
dichloromethane (DCM) extracts of mushroom 
Leucopaxillus gentianeus. In addition, the extracts 
have been shown to possess DNA protective action 
and cytotoxic effect on A549 cells. The mushroom 
extracts exhibited normal antimicrobial activity on 
tested micro-organisms (Staphylococcus aureus,  
S. aureus MRSA, Enterococcus faecalis, Escherichia 
coli, Pseudomonas aeruginosa, Acinetobacter 
baumannii and fungal strains). Their highest impact 
was on fungal strains (C. albicans, C. glabrata and  
C. krusei). Phenolic compounds such as gallic acid, 
catechin, epicatechin, cinnamic acid, chlorogenic acid 
and coumaric acid have been found to present in  
the mushroom. The above observations indicate the 
pharma-cological potential of the mushroom  
L. gentianeus as a natural source. 
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